Members of Guaranteed Irish, the not-for-profit business membership organisation championing 500+ homegrown and international businesses in Ireland, have called on the Government to set a target for Ireland to be in the top quartile of European countries for speed of access to the latest medicines.
The last decade has seen significant capital investment at pharmaceutical facilities across the country. However, industry leaders and representative bodies present at a recent Guaranteed Irish roundtable discussion – including IDA Ireland, the Irish Pharmaceutical and Healthcare Association, MSD Ireland and BioPharmaChem Ireland – raised a number of challenges facing the industry, including the slow access to new medicines, a lack of highly skilled graduates and fierce international competition for foreign direct investment.
For verified healthcare professionals
Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.
